(Q38498259)

3 September 2017

title

Use of B-type natriuretic peptide in the management of hypoxaemic respiratory failure (English)

1 reference

3 September 2017

1 reference

10

Alexandre Mebazaa

1 reference

3 September 2017

Markus Noveanu

1

1 reference

3 September 2017

Hans Pargger

2

1 reference

3 September 2017

Tobias Breidthardt

3

1 reference

3 September 2017

Tobias Reichlin

4

1 reference

3 September 2017

Christian Schindler

5

1 reference

3 September 2017

Antje Heise

6

1 reference

3 September 2017

Ronald Schoenenberger

7

1 reference

3 September 2017

Patricia Manndorff

8

1 reference

3 September 2017

Martin Siegemund

9

1 reference

3 September 2017

Stephan Marsch

11

1 reference

3 September 2017

Christian Mueller

12

1 reference

3 September 2017

publication date

29 October 2010

1 reference

European Journal of Heart Failure

3 September 2017

published in

1 reference

3 September 2017

volume

13

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

154-162

1 reference

The acute respiratory distress syndrome

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Clinical practice. Acute pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Diagnostic utility of B-type natriuretic peptide in critically ill patients with pulmonary edema: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Costs of adverse events in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Medical and economic long-term effects of B-type natriuretic peptide testing in patients with acute dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

B-type natriuretic peptide testing and the accuracy of heart failure diagnosis in the emergency department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Impact of obesity on plasma natriuretic peptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Statistics in medicine--reporting of subgroup analyses in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ188

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFQ188

1 reference

3 September 2017

1 reference